Informed Consent and Innovative Methods

About this session

Audience members will be invited to share institutional best practices and innovative approaches to informed consent. Session will feature internal work on a behavioral assent and thinking about needs in Alzheimer's Disease research.

Speakers

• KC

  Karla G. Childers

  Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer · Johnson & Johnson

  Speaker

• KF

  Kelly Fitzgerald

  IRB Executive Chair and Vice President of IBC Affairs · WCG

  Speaker

• 

  Sylvia Baedorf Kassis

  Program Director · MRCT Center

  Speaker